A phase I study of a pooled synthetic long peptide mutant KRAS vaccine in patients with pancreatic cystic neoplasms at risk for developing pancreatic cancer.

Authors: Kai-li Liang, Amanda Huff, S. Daniel Haldar, Anna Ferguson, Maureen Berg, Hao Wang, Julie Nauroth, Amy Thomas, Nancy Sun, Dan Laheru, William Burns, Richard Burkhart, Jin He, Kelly Lafaro, Laura D. Wood, Michael Goggins, Elizabeth M. Jaffee, Nilofer Saba Azad, Neeha Zaidi

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2699

Source: Full article

---

Abstract

TPS2699